Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lung cancer drug combo trial halted early

NCT ID NCT06267001

Terminated Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 37 times

Summary

This study tested adding tiragolumab to atezolizumab in people with non-small cell lung cancer who had surgery and chemotherapy. The goal was to see if the combination worked better than atezolizumab alone. The trial was stopped early, and only 56 people took part. The main focus was on safety and side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Asan Medical Center

    Seoul, 05505, South Korea

  • Bakirkoy Dr. Sadi Konuk Egitim ve Arastirma Hastanesi, Tibbi Onkoloji

    Bakirkoy / Istanbul, 34147, Turkey (Türkiye)

  • Centro Oncologico Korben

    Ciudad Autonoma Buenos Aires, C1426AGE, Argentina

  • Changzhou First People's Hospital

    Changzhou, 213003, China

  • Crio - Centro Regional Integrado de Oncologia

    Fortaleza, Ceará, 60336-232, Brazil

  • E-DA Hospital

    Kaohsiung City, 824, Taiwan

  • Hiroshima University Hospital

    Hiroshima, 734-8551, Japan

  • Hospital Nossa Senhora da Conceicao

    Porto Alegre, Rio Grande do Sul, 91350-200, Brazil

  • Hospital de Cancer de Barretos

    Barretos, São Paulo, 14784-400, Brazil

  • Hospital de Clínicas de Passo Fundo

    Passo Fundo, Rio Grande do Sul, 99010-260, Brazil

  • Instytut Gruzlicy I Chorob Pluc

    Warsaw, 01-138, Poland

  • Kindai University Hospital

    Osaka, 589-8511, Japan

  • Korea University Guro Hospital

    Seoul, 08308, South Korea

  • Kyungpook National University Chilgok Hospital

    Daegu, 41404, South Korea

  • Liaoning Provincial Cancer Hospital

    Shengyang, 110042, China

  • Monash Health

    Clayton, Victoria, 3168, Australia

  • Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School

    Nanjing, 210008, China

  • National Taiwan University Cancer Center

    Zhongzheng Dist., 106, Taiwan

  • Ningbo No.2 Hospital

    Ningbo, DUMMY_VALUE, China

  • Nucleo de Oncologia da Bahia - NOB

    Salvador, Bahia, Estado de Bahia, 40170-380, Brazil

  • Ospedale P. Pederzoli Casa di cura Privata

    Peschiera Del Garda (VR), Veneto, 37019, Italy

  • Pusan National University Hospital

    Busan, 602-739, South Korea

  • Pusan National University Yangsan Hospital

    Gyeongsangnam-do, 50612, South Korea

  • Samsung Medical Center

    Seoul, 06351, South Korea

  • Seoul National University Bundang Hospital

    Seongnam-si, 463-707, South Korea

  • Seoul National University Hospital

    Seoul, 03080, South Korea

  • Severance Hospital, Yonsei University Health System

    Seoul, 03722, South Korea

  • Shandong Cancer Hospital

    Jinan, 250117, China

  • St. Vincent's Hospital

    Gyeonggi-do, 16247, South Korea

  • Sunshine Coast University Hospital

    Birtinya, Queensland, 4575, Australia

  • Taichung Veterans General Hospital

    Taichung, 407, Taiwan

  • The First Affiliated Hospital of Sun Yat-sen University

    Guangzhou, 510080, China

  • Tianjin Cancer Hospital

    Tianjin, 300060, China

  • Tongji Hospital Tongji Medical College Huazhong University of Science and Technology

    Wuhan, 430030, China

  • Vajira Hospital

    Bangkok, 10300, Thailand

  • Yunnan Cancer Hospital

    Kunming, 650118, China

  • Zhejiang Cancer Hospital

    Zhejiang, 310022, China

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER (NSCLC) NON-SMALL CELL LUNG CANCER (NSCLC)